Kolinpharma Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Kolinpharma is forecast to grow revenue at 8.1% per annum.
Wichtige Informationen
n/a
Wachstumsrate der Gewinne
n/a
EPS-Wachstumsrate
| Personal Products Gewinnwachstum | 8.4% |
| Wachstumsrate der Einnahmen | 8.1% |
| Zukünftige Eigenkapitalrendite | 11.0% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 25 Oct 2023 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital
Jun 17
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?
Dec 01An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued
Aug 25We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt
Jun 08Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?
May 21Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?
May 03Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio
Apr 13What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?
Feb 20Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Dec 28These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well
Nov 22Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2025 | 20 | N/A | 2 | 4 | 1 |
| 12/31/2024 | 18 | N/A | 1 | 3 | 1 |
| 12/31/2023 | 16 | N/A | 1 | 3 | 1 |
| 12/31/2022 | 16 | 0 | 1 | 3 | N/A |
| 9/30/2022 | 14 | 0 | N/A | N/A | N/A |
| 6/30/2022 | 13 | 0 | -2 | -1 | N/A |
| 3/31/2022 | 13 | 0 | 0 | 1 | N/A |
| 12/31/2021 | 13 | 1 | 1 | 3 | N/A |
| 9/30/2021 | 13 | 1 | N/A | N/A | N/A |
| 6/30/2021 | 13 | 1 | 1 | 3 | N/A |
| 3/31/2021 | 11 | 1 | -1 | 1 | N/A |
| 12/31/2020 | 10 | 1 | -2 | -1 | N/A |
| 9/30/2020 | 9 | 1 | N/A | N/A | N/A |
| 6/30/2020 | 9 | 1 | 0 | 0 | N/A |
| 3/31/2020 | 10 | 1 | 0 | 1 | N/A |
| 12/31/2019 | 10 | 1 | 1 | 2 | N/A |
| 9/30/2019 | 10 | 0 | N/A | N/A | N/A |
| 6/30/2019 | 9 | 0 | 0 | 1 | N/A |
| 3/31/2019 | 9 | 0 | -1 | 1 | N/A |
| 12/31/2018 | 9 | 0 | -1 | 0 | N/A |
| 9/30/2018 | 8 | 0 | N/A | N/A | N/A |
| 6/30/2018 | 7 | 0 | -2 | 0 | N/A |
| 3/31/2018 | 6 | 0 | -1 | 0 | N/A |
| 12/31/2017 | 5 | 0 | -1 | 0 | N/A |
| 12/31/2016 | 4 | 0 | -1 | 0 | N/A |
| 12/31/2015 | 2 | -1 | N/A | N/A | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: Insufficient data to determine if KIP's forecast earnings growth is above the savings rate (2.2%).
Ertrag vs. Markt: Insufficient data to determine if KIP's earnings are forecast to grow faster than the Italian market
Hohe Wachstumserträge: Insufficient data to determine if KIP's earnings are expected to grow significantly over the next 3 years.
Einnahmen vs. Markt: KIP's revenue (8.1% per year) is forecast to grow faster than the Italian market (-0.2% per year).
Hohe Wachstumseinnahmen: KIP's revenue (8.1% per year) is forecast to grow slower than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: KIP's Return on Equity is forecast to be low in 3 years time (11%).